Early in the pandemic, with few clues about how to treat critically-ill COVID-19 patients, Stanford’s ICU team developed and shared expertise to save lives.
The COVID-19 pandemic gives new relevance to a synthetic substance developed by Stanford researchers that could help respiratory patients breathe easier.
Scientists at Stanford have developed a new PET scan tracer that flags both pancreatic cancer and a lung disease known as idiopathic pulmonary fibrosis.
Stanford Medicine pulmonologist Mark Nicolls is working with Nobel winner Gregg Semenza to boost the success of lung transplants.
Some viruses help drug-resistant bacteria grow in the lungs of cystic fibrosis patients, new Stanford research shows.
By scouting for a particular immune cell in the blood, scientists can tell which patients with a lung-scarring disease are at higher risk for death.
What makes breathing possible is a thin coating of a soaplike film, or surfactant, that lowers the tension of the lung’s inner surface. Premature babies and adults with lung injuries are short on surfactant, and replacing it has been prohibitively pricey. That may be about to change.
This Stars of Stanford Medicine Q&A features Kristina Kudelko, who specializes in pulmonary hypertension. She also runs, loves music and spending time with her family.
When I mention to people that I had a double lung transplant, they usually react in one of two ways. They're likely to say, “Wow, …
